Iizuka Mika, Sengoku Norihiko, Nakakuma Takashi, Yoshimura Naoko, Hayashi Keiko, Enomoto Takumo, Kuranami Masaru, Watanabe Masahiko
Dept. of Surgery, Ageo Chuo Hospital.
Gan To Kagaku Ryoho. 2008 Nov;35(12):2228-30.
We here describe a case of advanced breast cancer (Stage IV) in which an oral S-1+TAM therapy following a primary systemic chemo-radiotherapy has been effective in maintaining the patient's QOL. A 40-year-old woman visited our hospital because of her left breast tumor. On physical examination, the tumor had invaded to the skin adjacent to the nipple forming a skin ulcer and marked deformity of the entire breast. Also noted were swollen lymph nodes in the left armpit. Subsequently, radiographic imaging tests revealed that the tumor had metastasized to the liver and lungs, as well as the skull. Accordingly, a primary systemic chemotherapy (4 series of AC/T) was started and followed by local radiation therapy (60 Gys) immediately after completing the chemotherapy. The metastasizing lesions in the liver, lungs, and skull had markedly reduced in the size and number, and the skin ulceration had healed up by these treatments. Afterwards, she has been given TAM daily and S-1 for 4 weeks with a 2-week interval. She has been quite well without any adverse effects by S-1 and TAM, and the primary as well as metastasizing lesions remain stable with normalized tumor marker levels (NC) for nearly 3 years.
我们在此描述一例晚期乳腺癌(IV期)病例,其中在原发性全身放化疗后采用口服S-1加他莫昔芬(TAM)治疗对维持患者的生活质量有效。一名40岁女性因左乳肿瘤前来我院就诊。体格检查发现,肿瘤已侵犯至乳头附近皮肤,形成皮肤溃疡,整个乳房明显变形。还发现左侧腋窝淋巴结肿大。随后,影像学检查显示肿瘤已转移至肝脏、肺部以及颅骨。因此,开始进行原发性全身化疗(4个周期的AC/T方案),化疗结束后立即进行局部放射治疗(60 Gy)。经过这些治疗,肝脏、肺部和颅骨的转移病灶在大小和数量上均显著减少,皮肤溃疡也已愈合。此后,她每天服用TAM,并每4周服用1次S-1,间隔2周。她情况良好,未出现S-1和TAM的任何不良反应,原发灶和转移灶保持稳定,肿瘤标志物水平正常(NC)近3年。